BioVaxys Technology Current Assets

BioVaxys Technology (BVAXF) currently reports a current assets of $1.4M as of July 2025. That compares with $1M in the prior-year period — up 35.4% year over year. Use the charts on this page to explore BioVaxys Technology's current assets history and peer comparisons.

BioVaxys Technology's current assets increased from $1M to $1.4M — a 35.4% year-over-year increase (period ending July 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioVaxys Technology reported $1.4M in current assets as of July 2025. That compares with $1M in the prior-year period — up 35.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioVaxys Technology, and consider following BVAXF for alerts when major investors trade the stock.

BioVaxys Technology is classified in the Healthcare sector. On current assets, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BVAXF with unrelated industries.